Developing small molecule therapeutics to treat gastrointestinal disorders.
Industry: Health Care
First Day Return: 0.0%
Industry: Health Care
IPO Data | |
---|---|
IPO File Date | 11/19/2010 |
Offer Price | $4.00 |
Price Range $4.00 - $4.00 | |
Offer Shares (mm) | 13.5 |
Deal Size ($mm) | $54 |
Lock-Up Date | IPO Pro Only |
Street Research | IPO Pro Only |
IPO Data | |
---|---|
IPO Date | 04/01/2011 |
Offer Price | IPO Intelligence Only |
Price Range | IPO Intelligence Only |
Offer Shares (mm) | IPO Intelligence Only |
Deal Size ($mm) | $54 |
Lock-Up Date | IPO Intelligence Only |
Street Research | IPO Intelligence Only |
Underwriters |
---|
IPO Intelligence Only |
Company Data | |
---|---|
Headquarters | Durham, NC, United States |
Founded | 1998 |
Employees at IPO | 39 |
Website www.tranzyme.com |